Nongenotropic, anti-apoptotic signaling of 1α,25(OH) 2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes: Mediation by Src, phosphatidylinositol 3-, and JNK kinases

Anthony M. Vertino, Craig M. Bula, Jin Ran Chen, Maria Almeida, Li Han, Teresita Bellido, Stavroula Kousteni, Anthony W. Norman, Stavros C. Manolagas

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Because sex steroids regulate the life span of bone cells by modulating cytoplasmic kinase activity via a nongenotropic action of their classical receptors, we have explored the possibility that the vitamin D nuclear receptor (VDR) might exhibit similar nongenotropic actions. We report that the conformationally flexible full VDR agonist, 1α,25(OH)2-vitamin D3 (1α,25(OH)2D3), and the 6-s-cis-locked 1α,25(OH)2-lumisterol3 (JN) analog, also acting through the VDR but with poor transcriptional activity, protected murine osteoblastic or osteocytic cells from apoptosis. This effect was reproduced in HeLa cells transiently transfected with either wild type VDR or a mutant consisting of only the VDR ligand binding domain. The VDR ligand binding domain bound [3H]1α,25(OH)2D3 as effectively as wild type VDR but did not induce vitamin D response element-mediated transcription. The anti-apoptotic effects of 1α,25(OH)2D 3 and the 6-s-cis-locked 1α,25(OH)2-lumisterol 3 analog in calvaria cells were blocked by three cytoplasmic kinase inhibitors: Src kinase inhibitor 4-amino-5-(4-methylphenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP1), phosphatidylinositol 3 kinase inhibitor Wortmannin, and the JNK kinase inhibitor SP600125. However, inhibition of p38 with SB203580 or ERK with either U0126 or a transfected dominant negative MEK did not interfere with these anti-apoptotic actions. Further, 1α,25(OH)2D3 induced rapid (5 min) association of VDR with Src kinase in OB-6 cells. Finally, actinomycin D or cycloheximide prevented the anti-apoptotic effect of 1α,25(OH)2D3, indicating that transcriptional events are also required. These findings suggest that nongenotropic modulation of kinase activity is also a general property of the VDR and that ligands that activate nongenotropic signals, but lack transcriptional activity, display different biological profiles from the steroid hormone 1α,25(OH)2D3.

Original languageEnglish (US)
Pages (from-to)14130-14137
Number of pages8
JournalJournal of Biological Chemistry
Volume280
Issue number14
DOIs
StatePublished - Apr 8 2005
Externally publishedYes

Fingerprint

MAP Kinase Kinase 4
Osteocytes
Calcitriol Receptors
Cholecalciferol
Osteoblasts
Cytoplasmic and Nuclear Receptors
Phosphatidylinositols
Phosphatidylinositol 3-Kinases
Vitamin D
Ligands
Phosphotransferases
src-Family Kinases
Vitamin D Response Element
Steroid hormones
Steroids
Phosphatidylinositol 3-Kinase
Ergosterol
Mitogen-Activated Protein Kinase Kinases
Dactinomycin
Transcription

ASJC Scopus subject areas

  • Biochemistry

Cite this

Nongenotropic, anti-apoptotic signaling of 1α,25(OH) 2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes : Mediation by Src, phosphatidylinositol 3-, and JNK kinases. / Vertino, Anthony M.; Bula, Craig M.; Chen, Jin Ran; Almeida, Maria; Han, Li; Bellido, Teresita; Kousteni, Stavroula; Norman, Anthony W.; Manolagas, Stavros C.

In: Journal of Biological Chemistry, Vol. 280, No. 14, 08.04.2005, p. 14130-14137.

Research output: Contribution to journalArticle

Vertino, Anthony M. ; Bula, Craig M. ; Chen, Jin Ran ; Almeida, Maria ; Han, Li ; Bellido, Teresita ; Kousteni, Stavroula ; Norman, Anthony W. ; Manolagas, Stavros C. / Nongenotropic, anti-apoptotic signaling of 1α,25(OH) 2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes : Mediation by Src, phosphatidylinositol 3-, and JNK kinases. In: Journal of Biological Chemistry. 2005 ; Vol. 280, No. 14. pp. 14130-14137.
@article{5bbb154821034768b578c660f994c1d3,
title = "Nongenotropic, anti-apoptotic signaling of 1α,25(OH) 2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes: Mediation by Src, phosphatidylinositol 3-, and JNK kinases",
abstract = "Because sex steroids regulate the life span of bone cells by modulating cytoplasmic kinase activity via a nongenotropic action of their classical receptors, we have explored the possibility that the vitamin D nuclear receptor (VDR) might exhibit similar nongenotropic actions. We report that the conformationally flexible full VDR agonist, 1α,25(OH)2-vitamin D3 (1α,25(OH)2D3), and the 6-s-cis-locked 1α,25(OH)2-lumisterol3 (JN) analog, also acting through the VDR but with poor transcriptional activity, protected murine osteoblastic or osteocytic cells from apoptosis. This effect was reproduced in HeLa cells transiently transfected with either wild type VDR or a mutant consisting of only the VDR ligand binding domain. The VDR ligand binding domain bound [3H]1α,25(OH)2D3 as effectively as wild type VDR but did not induce vitamin D response element-mediated transcription. The anti-apoptotic effects of 1α,25(OH)2D 3 and the 6-s-cis-locked 1α,25(OH)2-lumisterol 3 analog in calvaria cells were blocked by three cytoplasmic kinase inhibitors: Src kinase inhibitor 4-amino-5-(4-methylphenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP1), phosphatidylinositol 3 kinase inhibitor Wortmannin, and the JNK kinase inhibitor SP600125. However, inhibition of p38 with SB203580 or ERK with either U0126 or a transfected dominant negative MEK did not interfere with these anti-apoptotic actions. Further, 1α,25(OH)2D3 induced rapid (5 min) association of VDR with Src kinase in OB-6 cells. Finally, actinomycin D or cycloheximide prevented the anti-apoptotic effect of 1α,25(OH)2D3, indicating that transcriptional events are also required. These findings suggest that nongenotropic modulation of kinase activity is also a general property of the VDR and that ligands that activate nongenotropic signals, but lack transcriptional activity, display different biological profiles from the steroid hormone 1α,25(OH)2D3.",
author = "Vertino, {Anthony M.} and Bula, {Craig M.} and Chen, {Jin Ran} and Maria Almeida and Li Han and Teresita Bellido and Stavroula Kousteni and Norman, {Anthony W.} and Manolagas, {Stavros C.}",
year = "2005",
month = "4",
day = "8",
doi = "10.1074/jbc.M410720200",
language = "English (US)",
volume = "280",
pages = "14130--14137",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "14",

}

TY - JOUR

T1 - Nongenotropic, anti-apoptotic signaling of 1α,25(OH) 2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes

T2 - Mediation by Src, phosphatidylinositol 3-, and JNK kinases

AU - Vertino, Anthony M.

AU - Bula, Craig M.

AU - Chen, Jin Ran

AU - Almeida, Maria

AU - Han, Li

AU - Bellido, Teresita

AU - Kousteni, Stavroula

AU - Norman, Anthony W.

AU - Manolagas, Stavros C.

PY - 2005/4/8

Y1 - 2005/4/8

N2 - Because sex steroids regulate the life span of bone cells by modulating cytoplasmic kinase activity via a nongenotropic action of their classical receptors, we have explored the possibility that the vitamin D nuclear receptor (VDR) might exhibit similar nongenotropic actions. We report that the conformationally flexible full VDR agonist, 1α,25(OH)2-vitamin D3 (1α,25(OH)2D3), and the 6-s-cis-locked 1α,25(OH)2-lumisterol3 (JN) analog, also acting through the VDR but with poor transcriptional activity, protected murine osteoblastic or osteocytic cells from apoptosis. This effect was reproduced in HeLa cells transiently transfected with either wild type VDR or a mutant consisting of only the VDR ligand binding domain. The VDR ligand binding domain bound [3H]1α,25(OH)2D3 as effectively as wild type VDR but did not induce vitamin D response element-mediated transcription. The anti-apoptotic effects of 1α,25(OH)2D 3 and the 6-s-cis-locked 1α,25(OH)2-lumisterol 3 analog in calvaria cells were blocked by three cytoplasmic kinase inhibitors: Src kinase inhibitor 4-amino-5-(4-methylphenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP1), phosphatidylinositol 3 kinase inhibitor Wortmannin, and the JNK kinase inhibitor SP600125. However, inhibition of p38 with SB203580 or ERK with either U0126 or a transfected dominant negative MEK did not interfere with these anti-apoptotic actions. Further, 1α,25(OH)2D3 induced rapid (5 min) association of VDR with Src kinase in OB-6 cells. Finally, actinomycin D or cycloheximide prevented the anti-apoptotic effect of 1α,25(OH)2D3, indicating that transcriptional events are also required. These findings suggest that nongenotropic modulation of kinase activity is also a general property of the VDR and that ligands that activate nongenotropic signals, but lack transcriptional activity, display different biological profiles from the steroid hormone 1α,25(OH)2D3.

AB - Because sex steroids regulate the life span of bone cells by modulating cytoplasmic kinase activity via a nongenotropic action of their classical receptors, we have explored the possibility that the vitamin D nuclear receptor (VDR) might exhibit similar nongenotropic actions. We report that the conformationally flexible full VDR agonist, 1α,25(OH)2-vitamin D3 (1α,25(OH)2D3), and the 6-s-cis-locked 1α,25(OH)2-lumisterol3 (JN) analog, also acting through the VDR but with poor transcriptional activity, protected murine osteoblastic or osteocytic cells from apoptosis. This effect was reproduced in HeLa cells transiently transfected with either wild type VDR or a mutant consisting of only the VDR ligand binding domain. The VDR ligand binding domain bound [3H]1α,25(OH)2D3 as effectively as wild type VDR but did not induce vitamin D response element-mediated transcription. The anti-apoptotic effects of 1α,25(OH)2D 3 and the 6-s-cis-locked 1α,25(OH)2-lumisterol 3 analog in calvaria cells were blocked by three cytoplasmic kinase inhibitors: Src kinase inhibitor 4-amino-5-(4-methylphenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP1), phosphatidylinositol 3 kinase inhibitor Wortmannin, and the JNK kinase inhibitor SP600125. However, inhibition of p38 with SB203580 or ERK with either U0126 or a transfected dominant negative MEK did not interfere with these anti-apoptotic actions. Further, 1α,25(OH)2D3 induced rapid (5 min) association of VDR with Src kinase in OB-6 cells. Finally, actinomycin D or cycloheximide prevented the anti-apoptotic effect of 1α,25(OH)2D3, indicating that transcriptional events are also required. These findings suggest that nongenotropic modulation of kinase activity is also a general property of the VDR and that ligands that activate nongenotropic signals, but lack transcriptional activity, display different biological profiles from the steroid hormone 1α,25(OH)2D3.

UR - http://www.scopus.com/inward/record.url?scp=17144428054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144428054&partnerID=8YFLogxK

U2 - 10.1074/jbc.M410720200

DO - 10.1074/jbc.M410720200

M3 - Article

C2 - 15671029

AN - SCOPUS:17144428054

VL - 280

SP - 14130

EP - 14137

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 14

ER -